Martin Avenue Pharmacy Recalls Tobramycin Eye Drops for Sterility Concerns
Martin Avenue Pharmacy is voluntarily recalling Tobramycin eye drops due to quality control issues that may compromise sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls involving significant risks such as sterility assurance failures in sterile preparations are categorized as Severe (Score 4), as they pose a risk of serious temporary or medically reversible health consequences.
Plain-English summary
Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within their expiry date. This action includes Tobramycin (PF) 15 mg/mL ophthalmic solution packaged in opaque squeeze bottle eye droppers. The specific lot number is 08012014@7, with an expiration date of 9/30/2014. The product was distributed nationwide.
The recall was initiated following a recent FDA inspection that identified observations associated with certain quality control procedures. These observations present a risk to the assurance of sterility for the compounded preparations. The agency has classified this recall as Class II.
Consumers who have this product should stop using it and contact Martin Avenue Pharmacy, Inc. or their healthcare provider for further instructions. The recall covers all compounded sterile preparations within expiry, not just the specific Tobramycin lot listed.
The recalled product
- Product
- Tobramycin (PF) 15 mg/mL opthalmic solution packaged in opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
- Manufacturer
- Martin Avenue Pharmacy, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number: 08012014@7
- Exp 9/30/2014
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Martin Avenue Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Martin Avenue Pharmacy, Inc.
See all →- SevereMartin Avenue Pharmacy Recalls Atropine Sulfate Eye Drops for Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereMartin Avenue Pharmacy Recalls Compounded Sterile Preparations Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereMartin Avenue Pharmacy Recalls Compounded Hydromorphone and Bupivacaine Injections
FDA (Drugs) · 2014-11-05
- HighMartin Avenue Pharmacy Recalls Tri-mix T50 Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- HighMartin Avenue Pharmacy Recalls Tri-mix ST2 Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighAntibiotic Eye Drops Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- SevereLiberty Drug Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- HighWalter's Pharmacy Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereHealth Innovations Pharmacy Recalls Fortifed Tobramycin Ophthalmic Solution
FDA (Drugs) · 2015-05-20
- SevereNatures Pharmacy Recalls Dexamethosone/Tobramycin Ophthalmic Drops for Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNora Apothecary Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05